May 30, 2026 · Form 4 insider transaction
Camardo Daniel A. bought 1,626 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 9 days after the transaction.
The shares underlying the option are scheduled to vest over three years with one-third vesting on the one-year anniversary of the grant date and the balance vesting in eight equal quarterly installments.